Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes

Molecular Therapy

Volumn 6, Issue 2, 2002, Pages 199-209

  Nguyen, Tuan Huy ^a   Oberholzer, José ^a   Birraux, Jacques ^a   Majno, Pietro ^a   Morel, Philippe ^a   Trono, Didier ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Gene transfer; Hepatocyte; Lentiviral vector; Transplantation

Indexed keywords

DNA; LENTIVIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIVISION; CELL SUSPENSION; CELL TRANSPLANTATION; CONTROLLED STUDY; DNA MODIFICATION; GENE EXPRESSION; GENETIC DISORDER; GENETIC MANIPULATION; GENETIC RESISTANCE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; LIVER CELL; LIVER DISEASE; METHODOLOGY; MOUSE; NONHUMAN; PHENOTYPE; RAT; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS DNA CELL DNA INTERACTION; VIRUS INFECTION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS; MURINAE; RODENTIA;

EID: 0036664451     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2002.0653     Document Type: Article

References (45)

1. Mulligan, R. (1993). The basic science of gene therapy. Science 260: 926-932.
2. Michalopoulos, G., and DeFrances, M. (1997). Liver regeneration. Science 276: 60-66.
3. Li, Q., Kay, M., Finegold, M., Stratford-Perricaudet, L., and Woo, S. (1993). Assessment of recombinant adenoviral vectors for hepatic gene therapy. Hum. Gene Ther. 4: 403-409.
4. Snyder, R., et al. (1997). Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat. Genet. 16: 270-276.
5. Miller, D., Adam, M., and Miller, A. (1990). Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol. Cell. Biol. 10: 4239-4242.
6. Webber, E. M., Godowski, P. J. and Fausto, N. (1994). In vivo response of hepatocytes to growth factors requires an initial priming stimulus. Hepatology 19: 489-497.
7. Runge, D. M., et al. (1999). Epidermal growth factor- and hepatocyte growth factor-receptor activity in serum-free cultures of human hepatocytes. J. Hepatol. 30: 265-274.
8. Gomez-Lechon, M. J., et al. (1995). Effects of hepatocyte growth factor on the growth and metabolism of human hepatocytes in primary culture. Hepatology 21: 1248-1254.
9. Naldini, L., et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
10. Bosch, A., Perret, E., Desmaris, N., Trono, D., and Heard, J. (2000). Reversal of pathology in the entire brain of mucopolysaccharidosis type VII mice after lentivirus-mediated gene transfer. Hum. Gene Ther. 11: 1139-1150.
11. Kordower, J., et al. (2000). Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290: 767-773.
12. Kafri, T., Blomer, U., Peterson, D. A., Gage, F. H., and Verma, I. M. (1997). Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17: 314-317.
13. Park, F., Ohashi, K., Chiu, W., Naldini, L., and Kay, M. (2000). Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat. Genet. 24: 49-52.
14. Pfeifer, A., et al. (2001). Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging. Mol. Ther. 3: 319-322, doi:10.1006/mthe2001.0276.
15. Chowdhury, J. R., et al. (1991). Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. Science 254: 1802-1805.
16. Grossman, M., et al. (1994). Successful ex vivo gene therapy directed to liver in a patient with familial hypercholesterolaemia. Nat. Genet. 6: 335-341.
17. Grossman, M., et al. (1995). A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolemia. Nat. Med. 1: 1148-1154.
18. Klages, N., Zufferey, R., and Trono, D. (2000). A stable system for the high-titer production of multiply attenuated lentiviral vectors. Mol. Ther. 2: 170-176, doi:10.1006/mthe2000.0103.
19. Chun, T., et al. (1997). Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 94: 13193-13197.
20. Follenzi, A., Ailles, L., Bakovic, S., Geuna, M., and Naldini, L. (2000). Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. 25: 217-222.
21. Zennou, V., et al. (2000). HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 10: 173-185.
22. Lori, F., et al. (1992). Viral DNA carried by human immunodeficiency virus type 1 virions. J. Virol 66: 5067-5074.
23. Trono, D. (1992). Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses. J. Virol. 66: 4893-4900.
24. Turelli, P. et al. (2001). Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication. Mol. Cell 7: 1245-1254.
25. Simon, J., et al. (1998). The regulation of primate immunodeficiency virus infectivity by Vif is cell species restricted: a role for Vif in determining virus host range and cross-species transmission. EMBO J. 17: 1259-1267.
26. Planelles, V., et al. (1996). Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J. Virol, 70: 2516-2524.
27. Stivahtis, G., Soares, M., Vodicka, M., Hahn, B., and Emerman, M. (1997). Conservation and host specificity of Vpr-mediated cell cycle arrest suggest a fundamental role in primate lentivirus evolution and biology. J. Virol. 71: 4331-4338.
28. Hart, C., et al. (1989). Human chromosome 12 is required for elevated HIV-1 expression in human-hamster hybrid cells. Science 246: 488-491.
29. Trono, D., and Baltimore, D. (1990). A human cell factor is essential for HIV-1 Rev action. EMBO J. 9: 4155-4160.
30. Hofmann, W., et al. (1999). Species-specific, postentry barriers to primate immunodeficiency virus infection. J. Virol. 73: 10020-10028.
31. Gupta, S., et al. (1999). Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium. Hepatology 29: 509-519.
32. Ponder, K. P., et al. (1991). Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation. Proc. Natl. Acad. Sci. USA 88: 1217-1221.
33. Rajvanshi, P., Kerr, A., Bhargava, K. K., Burk, R. D., and Gupta, S. (1996). Efficacy and safety of repeated hepatocyte transplantation for significant liver repopulation in rodents. Gastroenterology 111: 1092-1102.
34. Yoshida, Y., Tokusashi, Y., Lee, G. H., and Ogawa, K. (1996). Intrahepatic transplantation of normal hepatocytes prevents Wilson's disease in Long-Evans cinnamon rats. Gastroenterology 111: 1654-1660.
35. Wilson, J. M., et al. (1990). Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes. Proc. Natl. Acad. Sci. USA 87: 8437-8441.
36. Ferry, N., Duplessis, O., Houssin, D., Danos, O., and Heard, J.M. (1991). Retroviral-mediated gene transfer into hepatocytes in vivo. Proc. Natl. Acad. Sci. USA 88: 8377-8381.
37. Fox, I. J., et al. (1998). Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N. Engl. J. Med. 338: 1422-1426.
38. Chowdhury, J. R. (1999). Foreword: prospects of liver cell transplantation and liver-directed gene therapy. Semin. Liver Dis. 19: 1-6.
39. Gupta, S., Gorla, G. R., and Irani, A. N. (1999). Hepatocyte transplantation: emerging insights into mechanisms of liver repopulation and their relevance to potential therapies. J. Hepatol. 30: 162-170.
40. De Vree, J. M., et al. (2000). Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology 119: 1720-1730.
41. Weber-Benarous, A., et al. (1993). Retroviral infection of primary hepatocytes from normal mice and mice transgenic for SV40 large T antigen. Exp. Cell. Res. 205: 91-100.
42. Pages, J., et al. (1995). Efficient retroviral-mediated gene transfer into primary culture of murine and human hepatocytes: expression of the LDL receptor. Hum. Gene Ther. 6: 21-30.
43. Bonelo, A., et al. (2000). Generation and characterization of malaria-specific human CD8(+) lymphocyte clones: effect of natural polymorphism on T cell recognition and endogenous cognate antigen presentationby liver cells. Eur. J. Immunol. 30: 3079-3088.
44. Dull, T., et al. (1998). A third-generation lentivirus vector with a conditional packaging system. J. Virol. 82: 8463-8771.
45. Birraux, J., et al. (1998). Does hepatocyte transplantation in a chemically induced acute hepatic failure make sense? Eur. J. Pediatr. Surg. 8: 224-229.